A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2002
12/27/2002	CA2418102A1 Combretastatin a-3 prodrug
12/26/2002	US20020198571 Methods of indirectly stimulating the vagus nerve with an electrical field
12/26/2002	US20020198570 Apparatus for indirectly stimulating the vagus nerve with an electrical field
12/26/2002	US20020198415 Producing vegetation water from olives; adding acid; incubating the acidified vegetation water for a period of at least two months, until at least 75% of oleoeuropein has been converted to hydroxytyrosol
12/26/2002	US20020198407 Antiallergy agents and bronchodilators
12/26/2002	US20020198396 Oxime-group containing oestrone sulphatase inhibitors
12/26/2002	US20020198387 Reacting N-alkylpiperidine with a haloformic acid ester to prepare an alkoxycarbonylpiperidine, hydrolyzing
12/26/2002	US20020198382 For therapy and prophylaxis disorders caused by disturbances of glucose and/or lipid metabolism, such as, for example diabetes type 2, and other insulin-resistant conditions
12/26/2002	US20020198377 For improving perception, concentration power, learning power and/ or memory power
12/26/2002	US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002	US20020198259 Treatment of disease caused by procedural vascular trauma and/or an increased level of plasma homocysteine
12/26/2002	US20020198255 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists
12/26/2002	US20020198253 Melatonin derivatives and medicine containing same
12/26/2002	US20020198245 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002	US20020198244 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002	US20020198242 Administering to an animal an effective dose of atleast an enzyme Dipeptidyl Peptidase (DP IV) enzyme activity effector to increase the capacity of insulin producing cells
12/26/2002	US20020198238 Bipyridyl compounds with specific physical properties are potent and selective cyclooxygenase-2 (COX-2) inhibitor
12/26/2002	US20020198237 2,5-substituted imidazole compounds useful as histamine H3 receptor mediators
12/26/2002	US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002	US20020198232 4-substituted quinoline derivatives
12/26/2002	US20020198226 Administration of an opioid analgesic agent(such as morphine, codeine, methadone and fentanyl) and a compound that binds to the SS1 or SS2 subunit of a sodium channel , such as tetrodotoxin and saxitonxin and derivatives
12/26/2002	US20020198225 Administering a competitive inhibitor of the enzyme in an amount effective to enhance enzyme activtiy, selected from 2,5-dideoxy- 2,5-imino-D-mannitol, 3,4-diepi- alpha -homonojirimycin, 5-O- deoxyglactonojirimycin, calystegines
12/26/2002	US20020198219 2-pyridinamine compositions and related methods
12/26/2002	US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents
12/26/2002	US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/26/2002	US20020198210 Alpha-2-adrenergic agonist/fatty acid compositions
12/26/2002	US20020198206 Such as 1-Cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors
12/26/2002	US20020198200 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators
12/26/2002	US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis
12/26/2002	US20020198197 Metabotropic glutamate receptor agonist for treatment or prevention of acute and/or chronic neurological disorders
12/26/2002	US20020198196 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002	US20020198179 An estrogen or prodrug micture for reducing or eliminating the incidence of hot flashes and menopausal symptoms, while decreasing the risk of acquiring breast or endometrial cancer, inhibiting the development of osteoporosis
12/26/2002	US20020198170 Formulations of adenosine a1 agonists
12/26/2002	US20020198160 Compositions and methods for enhancing the bioavailability of pharmaceutical agents
12/26/2002	US20020198158 A cyclic ether conatining atleast 3 carbon atoms; sugars; useful as antidiabetic agents
12/26/2002	US20020198155 Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders
12/26/2002	US20020198154 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
12/26/2002	US20020198153 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent
12/26/2002	US20020198152 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor
12/26/2002	US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002	US20020198136 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc.
12/26/2002	US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression
12/26/2002	US20020197700 Receptor of the EDb-fibronectin domains
12/26/2002	US20020197692 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
12/26/2002	US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
12/26/2002	US20020197602 Nucleic acid sequences and proteins associated with aging
12/26/2002	US20020197598 Two hybrid assay that detects hiv-1 reverse transcriptase dimerization
12/26/2002	US20020197337 Hypericum Perforatum L. Oleoresin, Procedure for Obtaining it and Uses of it
12/26/2002	US20020197266 Immunotherapy using interleukin 13 receptor subunit alpha 2
12/26/2002	US20020197235 Method for short-term and long-term drug dosimetry
12/26/2002	CA2391588A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one anti-inflammatory compound
12/26/2002	CA2391585A1 Cosmetic or dermatological composition including an association between a compound of the n-acylamino amides family and at least one matrix metalloproteinase inhibitor
12/25/2002	CN1387575A Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
12/25/2002	CN1387569A Apoptin-associating protein
12/25/2002	CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
12/25/2002	CN1387537A Pharmaceutical compositions and methods of using secreted frizzled related protein
12/25/2002	CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002	CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387527A Qinazoline derivs. as VEGF inhibitors
12/25/2002	CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/25/2002	CN1387519A 2-imino-1,3-thiazine derivs.
12/25/2002	CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists
12/25/2002	CN1387517A 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions contg. them
12/25/2002	CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines
12/25/2002	CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002	CN1387513A Positive modulators of nicotinic receptor agonists
12/25/2002	CN1387512A Positive modulators for nicotinic receptor agonists
12/25/2002	CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity
12/25/2002	CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/25/2002	CN1387450A Use of dopamine-D3 receptor agonists for therapy of salt-dependent hypertension
12/25/2002	CN1387441A Use of nitric oxide for treatment of airway constriction
12/25/2002	CN1387437A 治疗用途 Therapeutic use
12/25/2002	CN1387434A Synergistic combinations of NK1 receptor antagonist and GABA structural analog
12/25/2002	CN1387433A Method for administering phosphodiesterase 4 inhibitor
12/25/2002	CN1387432A Methods of sing rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfnction
12/25/2002	CN1387404A Method and compositions for treating pulmonary diseases
12/25/2002	CN1386737A Antifibrosis pyridinone medicine and its prepaing process
12/25/2002	CN1386531A Chinese medicine for treating syringomyelia
12/25/2002	CN1386525A Formulation for face-beautifying product
12/25/2002	CN1386509A Process for preparing colostrum from pig's antibody serum for piglet
12/25/2002	CN1386505A Application of Na-ion channel blocker and opium antalgesic in preparing synergic antalgic medicine for mammal
12/25/2002	CN1386503A Combined therapy for treating alcoholism and addiction of alcohol
12/25/2002	CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002	CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/25/2002	CN1096863C Chinese medicine berb preparation of eliminating human body medicine and waste residuum
12/25/2002	CN1096834C Flavonol contg. food supplements
12/24/2002	US6498945 Free radical generation of water soluble polymer to enhance cytopathogenic efficacy
12/24/2002	US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/24/2002	US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002	US6498252 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/24/2002	US6498244 Adeno-associated virus capsid immunologic determinants
12/24/2002	US6498243 Epimorphin antagonist and process for producing it
12/24/2002	US6498234 Compounds
12/24/2002	US6498195 For prophylaxis and therpy of cancer
12/24/2002	US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke
12/24/2002	US6498187 Fatty acid synthase inhibitors
12/24/2002	US6498185 Enzyme factor xa inhibitors
12/24/2002	US6498178 Inhibitors of IMPDH enzyme

1 ... 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 ... 1564